Reduction of Risk Factors for ACL Re-injuries Using a Novel Biofeedback Approach

Anterior Cruciate Ligament Injury Clinical Trial

Official title:

Reduction of Risk Factors for ACL Re-injuries Using an Innovative Biofeedback Approach

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03273673
• Other study ID #: 17-007
• Secondary ID: R21AR069865-01A1
• Status: Completed
• Phase: N/A
• Start date: March 20, 2018
• Est. completion date: May 5, 2020

Study information

• Verified date: December 2020
• Source: Virginia Polytechnic Institute and State University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

ACL injuries are common among athletes and due to residual muscle weakness, limited knee motion and asymmetrical movement patterns after surgery many of these athletes will sustain secondary ACL injuries following return to sports. This project seeks to determine if a novel biofeedback-based rehabilitation approach can decrease a known risk factor for secondary injuries to the ACL. The project specifically focuses on correcting asymmetric movement patterns, a known risk factor for secondary injury that is not directly addressed by existing interventions through a 6 week therapy based biofeedback intervention.

Description:

Nearly 1 in 60 adolescent athletes will suffer ACL injuries. Approximately 90% of these injured athletes will undergo an ACL reconstruction at an estimated annual cost of $3 billion. While reconstruction and subsequent rehabilitation allow these athletes to return to sports, they have a 15 fold increased risk of secondary ACL injuries, a tear of the ACL graft or the contralateral ACL. As a result, development of an intervention to reduce the incidence of secondary ACL tears would meet a critical need. One area in which existing interventions might be improved is through an increased emphasis on correcting asymmetric movement patterns-a known risk factor for secondary injury. Thus, our long-term objective is to decrease the number of secondary ACL tears by decreasing side-to-side movement and loading asymmetry. The modification of post-operative rehabilitation to focus on movement and loading symmetry with shift the rehabilitation paradigm. Specifically, we propose to evaluate a novel biofeedback training program that focuses on altering loading and movement patterns to improve symmetry and overall lower extremity mechanics in a group of 40 (20 control, 20 intervention) adolescent ACL reconstructed patients. There are two core hypotheses of this study: 1) biofeedback training will decrease known risk factors for secondary ACL injuries immediately following the biofeedback program and these changes will be retained 6 week after the completion of the biofeedback program; and 2) we will be able to recruit and enroll 40 patients and retain 80% of the patients through the end of the follow-up assessment demonstrating the feasibility of the biofeedback intervention. Implementation of a biofeedback program prior to returning to dynamic athletic activities could improve physical performance outcomes, decrease secondary injury risk factors and ultimately decrease the long-term joint degeneration and development of osteoarthritis that has been associated with ACL reconstruction. Ultimately this work will lead to additional investigations to definitively determine the impact of this novel biofeedback program, which could shift the post-operative rehabilitation paradigm following ACL reconstruction to improve long-term joint health in these adolescent patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: May 5, 2020
• Est. primary completion date: May 5, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 14 Years to 21 Years

Eligibility

Inclusion Criteria:

1. Provision of signed and dated informed consent form

2. ACL Reconstruction: primary, unilateral ACL reconstruction with no pain in the contralateral leg

3. Rehabilitation: need to have completed at least 4.5 months of post-operative physical therapy and be within approximately 6 weeks of being ready to be released by his/her treating orthopaedic surgeon to return to full sport participation

4. Stated willingness to comply with all study procedures and availability for the duration of the study

5. Male or female, aged 14-21

6. Willing to adhere to the ACL Biofeedback intervention regimen

Exclusion Criteria:

1. For females: currently pregnant or planning to become pregnant

2. History of more than one ACL reconstruction

3. Post-operative complications that required additional surgical intervention

4. Hospitalization for any reason other than the ACL reconstruction in the last 3 months

5. Plans for additional surgical procedures in the next 12 months

6. Live greater than 60 miles from the research lab

7. Have limitations that would prevent them from attending the biofeedback training sessions

8. Motor neuron diseases, Parkinson's disease, multiple sclerosis

9. Severely impaired hearing or speech (patients must be able to respond to phone calls)

10. No access to a telephone

11. Participating in another ACL intervention

12. Inability to understand or speak English (since this will be required for the patient-based intervention)

13. Other self-reported medical problem that would prohibit participation in the study

14. Other health condition or personal issue judged by a study team member or primary care physician to make the patient inappropriate for study participation

15. Knee extension moment limb symmetry index (LSI) greater than or equal to 90% at the time of the initial study assessment

Related Conditions & MeSH terms

• Anterior Cruciate Ligament Injuries
• Anterior Cruciate Ligament Injury
• Wounds and Injuries

Intervention

Other:
• Biofeedback Intervention
Visual and Tactile Biofeedback

Locations

Country	Name	City	State
United States	Virginia Tech - Kevin P. Granata Biomechanics Lab	Blacksburg	Virginia

Sponsors (2)

Lead Sponsor	Collaborator
Virginia Polytechnic Institute and State University	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Peak Knee Extension Moment Symmetry	The peak knee extension moment asymmetry will be assessed during the first landing of a stop-jump task	Baseline (week 0) and Post-intervention (week 6)
Primary	Change in Peak Knee Extension Moment Symmetry	The peak knee extension moment asymmetry will be assessed during the first landing of a stop-jump task	Post-intervention (week 6) and Retention (week 12)
Secondary	Change in Frontal Plane Knee Range of Motion	The frontal plane knee range of motion will be assessed during the first landing of a stop-jump task	Baseline (week 0) and Post-intervention (week 6)
Secondary	Change in Frontal Plane Knee Range of Motion	The frontal plane knee range of motion will be assessed during the first landing of a stop-jump task	Post-intervention (week 6) and Retention (week 12)
Secondary	Change in Peak Vertical Ground Reaction Force Symmetry	The peak vertical ground reaction force symmetry will be assessed during the first landing of a stop-jump task	Baseline (week 0) and Post-intervention (week 6)
Secondary	Change in Peak Vertical Ground Reaction Force Symmetry	The peak vertical ground reaction force symmetry will be assessed during the first landing of a stop-jump task	Post-intervention (week 6) and Retention (week 12)